Top

Irish Journal of Medical Science (1971 -)

Published in:

01-05-2020 | Back Pain | Original Article

The effect of spinal manipulation on brain neurometabolites in chronic nonspecific low back pain patients: a randomized clinical trial

Authors: Daryoush Didehdar, Fahimeh Kamali, Amin Kordi Yoosefinejad, Mehrzad Lotfi

Published in: Irish Journal of Medical Science (1971 -) | Issue 2/2020

Abstract

Background

In patients with chronic nonspecific low back pain (NCLBP), brain function changes due to the neuroplastic changes in different regions.

Aim

The current study aimed to evaluate the brain metabolite changes after spinal manipulation, using proton magnetic resonance spectroscopy (¹H-MRS).

Methods

In the current study, 25 patients with NCLBP aged 20–50 years were enrolled. Patients were randomly assigned to lumbopelvic manipulation or sham. Patients were evaluated before and 5 weeks after treatment by the Numerical Rating Scale (NRS), the Oswestry Disability Index (ODI), and ¹H-MRS.

Results

After treatment, severity of pain and functional disability were significantly reduced in the treatment group vs. sham group (p < 0.05). After treatment, N-acetyl aspartate (NAA) in thalamus, insula, dorsolateral prefrontal cortex (DLPFC) regions, as well as choline (Cho) in the thalamus, insula, and somatosensory cortex (SSC) regions, had increased significantly in the treatment group compared with the sham group (p < 0.05). A significant increase was further observed in NAA in thalamus, anterior cingulate cortex (ACC), and SCC regions along with Cho metabolite in thalamus and SCC regions after treatment in the treatment group compared with the baseline measures (p < 0.05). Also, a significant increase was observed in Glx (glutamate and glutamine) levels of thalamus (p = 0.03). There was no significant difference in terms of brain metabolites at baseline and after treatment in the sham group.

Conclusion

In the patient with low back pain, spinal manipulation affects the central nervous system and changes the brain metabolites. Consequently, pain and functional disability are reduced.

Kamper SJ, Apeldoorn A, Chiarotto A, Smeets R, Ostelo R, Guzman J, Van Tulder M (2015) Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis. Bmj 350:h444PubMedPubMedCentralCrossRef

Zhao X, Xu M, Jorgenson K, Kong J (2017) Neurochemical changes in patients with chronic low back pain detected by proton magnetic resonance spectroscopy: a systematic review. NeuroImage: Clin 13:33–38CrossRef

Koes B, Van Tulder M, Thomas S (2006) Diagnosis and treatment of low back pain. Bmj 332(7555):1430–1434PubMedPubMedCentralCrossRef

Manchikanti L, Singh V, Datta S, Cohen SP, Hirsch JA (2009) Comprehensive review of epidemiology, scope, and impact of spinal pain. Pain physician 12(4):E35–E70PubMed

Coderre TJ, Katz J, Vaccarino AL, Melzack R (1993) Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52(3):259–285PubMedCrossRef

Tracey I, Bushnell MC (2009) How neuroimaging studies have challenged us to rethink: is chronic pain a disease? J pain 10 (11):1113-1120

Hardy JD, Wolff HG, Goodell H (1950) Experimental evidence on the nature of cutaneous hyperalgesia. J Clin Invest 29(1):115–140PubMedPubMedCentralCrossRef

O’Neill S, Manniche C, Graven-Nielsen T, Arendt-Nielsen L (2007) Generalized deep-tissue hyperalgesia in patients with chronic low-back pain. Eur J Pain 11(4):415–420. https://doi.org/10.1016/j.ejpain.2006.05.009 PubMedCrossRef

Giesecke T, Gracely RH, Grant MAB, Nachemson A, Petzke F, Williams DA, Clauw DJ (2004) Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum 50 (2):613-623. Doi:doi:https://doi.org/10.1002/art.20063

10.

Castro-Sánchez AM, Lara-Palomo IC, Matarán-Peñarrocha GA, Fernández-de-las-Peñas C, Saavedra-Hernández M, Cleland J, Aguilar-Ferrándiz ME (2016) Short-term effectiveness of spinal manipulative therapy versus functional technique in patients with chronic nonspecific low back pain: a pragmatic randomized controlled trial. Spine J 16(3):302–312PubMedCrossRef

11.

Kregel J, Meeus M, Malfliet A, Dolphens M, Danneels L, Nijs J, Cagnie B (2015) Structural and functional brain abnormalities in chronic low back pain: a systematic review. Semin Arthritis Rheum 45(2):229–237PubMedCrossRef

12.

Grachev I, Fredrickson B, Apkarian A (2002) Brain chemistry reflects dual states of pain and anxiety in chronic low back pain. J Neural Transm 109(10):1309–1334PubMedCrossRef

13.

Grachev I, Ramachandran T, Thomas P, Szeverenyi N, Fredrickson B (2003) Association between dorsolateral prefrontal N-acetyl aspartate and depression in chronic back pain: an in vivo proton magnetic resonance spectroscopy study. J Neural Transm 110(3):287–312PubMedCrossRef

14.

Grachev ID, Fredrickson BE, Apkarian AV (2000) Abnormal brain chemistry in chronic back pain: an in vivo proton magnetic resonance spectroscopy study. Pain 89(1):7–18CrossRef

15.

Siddall PJ, Stanwell P, Woodhouse A, Somorjai RL, Dolenko B, Nikulin A, Bourne R, Himmelreich U, Lean C, Cousins MJ (2006) Magnetic resonance spectroscopy detects biochemical changes in the brain associated with chronic low back pain: a preliminary report. Anesth Analg 102(4):1164–1168PubMedCrossRef

16.

Rubinstein SM, van Middelkoop M, Assendelft WJ, de Boer MR, van Tulder MW (2011) Spinal manipulative therapy for chronic low-back pain. Cochrane Database Syst Rev (2):Cd008112. DOI:DOI:https://doi.org/10.1002/14651858.CD008112.pub2

17.

Chown M, Whittamore L, Rush M, Allan S, Stott D, Archer M (2008) A prospective study of patients with chronic back pain randomised to group exercise, physiotherapy or osteopathy. Physiotherapy 94(1):21–28CrossRef

18.

Globe G, Farabaugh RJ, Hawk C, Morris CE, Baker G, Whalen WM, Walters S, Kaeser M, Dehen M, Augat T (2016) Clinical practice guideline: chiropractic care for low back pain. J Manip Physiol Ther 39(1):1–22CrossRef

19.

Hidalgo B, Detrembleur C, Hall T, Mahaudens P, Nielens H (2014) The efficacy of manual therapy and exercise for different stages of non-specific low back pain: an update of systematic reviews. J Manual Manipulative Ther 22(2):59–74CrossRef

20.

Orrock PJ, Myers SP (2013) Osteopathic intervention in chronic non-specific low back pain: a systematic review. BMC Musculoskelet Disord 14(1):129PubMedPubMedCentralCrossRef

21.

Haavik H, Murphy B (2012) The role of spinal manipulation in addressing disordered sensorimotor integration and altered motor control. J Electromyogr Kinesiol 22(5):768–776PubMedCrossRef

22.

Gussew A, Rzanny R, Güllmar D, Scholle H-C, Reichenbach JR (2011) 1H-MR spectroscopic detection of metabolic changes in pain processing brain regions in the presence of non-specific chronic low back pain. Neuroimage 54(2):1315–1323PubMedCrossRef

23.

Harris RE, Clauw DJ (2012) Imaging central neurochemical alterations in chronic pain with proton magnetic resonance spectroscopy. Neurosci Lett 520(2):192–196. https://doi.org/10.1016/j.neulet.2012.03.042 PubMedCrossRef

24.

Schmidt-Wilcke T (2015) Neuroimaging of chronic pain. Best Pract Res Clin Rheumatol 29(1):29–41PubMedCrossRef

25.

Sharma NK, Brooks WM, Popescu AE, VanDillen L, George SZ, McCarson KE, Gajewski BJ, Gorman P, Cirstea CM (2012) Neurochemical analysis of primary motor cortex in chronic low back pain. Brain sci 2(3):319–331PubMedPubMedCentralCrossRef

26.

Yabuki S, S-i K, S-i K (2013) Assessment of pain due to lumbar spine diseases using MR spectroscopy: a preliminary report. J Orthop Sci 18(3):363–368PubMedPubMedCentralCrossRef

27.

Lin A, Ramadan S, Stanwell P, Luu T, Celestin J, Bajwa Z, Mountford C (2010) In vivo L-COSY MR distinguishes glutamate from glutamine and shows neuropathic pain to cause a build up of glutamine in the brain. Proc Int Soc Magn Reson Med 18:381

28.

Plitman E, Chavez S, Nakajima S, Iwata Y, Chung JK, Caravaggio F, Kim J, Alshehri Y, Chakravarty MM, De Luca V (2018) Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: a proton magnetic resonance spectroscopy and reliability study. Psychiatry Res Neuroimaging 273:16–24PubMedCrossRef

29.

Kamali F, Shokri E (2012) The effect of two manipulative therapy techniques and their outcome in patients with sacroiliac joint syndrome. J Bodyw Mov Ther 16(1):29–35PubMedCrossRef

30.

Kent P, Keating JL (2005) Classification in nonspecific low back pain: what methods do primary care clinicians currently use? Spine 30(12):1433–1440PubMedCrossRef

31.

Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94(2):149–158CrossRef

32.

Mousavi SJ, Parnianpour M, Mehdian H, Montazeri A, Mobini B (2006) The Oswestry disability index, the Roland-Morris disability questionnaire, and the Quebec back pain disability scale: translation and validation studies of the Iranian versions. Spine 31(14):E454–E459PubMedCrossRef

33.

Davidson M, Keating JL (2002) A comparison of five low back disability questionnaires: reliability and responsiveness. Phys Ther 82(1):8–24PubMedCrossRef

34.

May A (2008) Chronic pain may change the structure of the brain. Pain 137(1):7–15PubMedCrossRef

35.

Wand BM, Parkitny L, O’Connell NE, Luomajoki H, McAuley JH, Thacker M, Moseley GL (2011) Cortical changes in chronic low back pain: current state of the art and implications for clinical practice. Manual Ther 16(1):15–20CrossRef

36.

Alleva J, Hudgins T, Belous J, Origenes AK (2016) Chronic low back pain. Disease-a-Month. 9(62):330–333CrossRef

37.

Pickar JG, Bolton PS (2012) Spinal manipulative therapy and somatosensory activation. J Electromyogr Kinesiol 22(5):785–794PubMedPubMedCentralCrossRef

38.

Pickar JG (2002) Neurophysiological effects of spinal manipulation. Spine J 2(5):357–371PubMedCrossRef

39.

Yuan W, Shen Z, Xue L, Tan W, Cheng Y, Zhan S, Zhan H (2015) Effect of spinal manipulation on brain functional activity in patients with lumbar disc herniation. J Zhejiang Univ Med Sci 44(2):124–130

40.

Kaňovský P, Bareš M, Rektor I (2003) The selective gating of the N30 cortical component of the somatosensory evoked potentials of median nerve is different in the mesial and dorsolateral frontal cortex: evidence from intracerebral recordings. Clin Neurophysiol 114(6):981–991PubMedCrossRef

41.

Taylor HH, Murphy B (2010) Altered central integration of dual somatosensory input after cervical spine manipulation. J Manip Physiol Ther 33(3):178–188CrossRef

42.

Gedin F, Dansk V, Egmar A-C, Sundberg T, Burström K (2018) Patient-reported improvements of pain, disability and health-related quality of life following chiropractic care for back pain–a national observational study in Sweden. J Bodyw Mov Ther doi. https://doi.org/10.1016/j.jbmt.2018.02.012

43.

Coulter ID, Crawford C, Hurwitz EL, Vernon H, Khorsan R, Booth MS, Herman PM (2018) Manipulation and mobilization for treating chronic low back pain: a systematic review and meta-analysis. Spine J 18(5):866–879PubMedPubMedCentralCrossRef

44.

Licciardone JC, Gatchel RJ, Aryal S (2016) Recovery from chronic low back pain after osteopathic manipulative treatment: a randomized controlled trial. J Am Osteopath Assoc 116(3):144–155PubMedCrossRef

Title: The effect of spinal manipulation on brain neurometabolites in chronic nonspecific low back pain patients: a randomized clinical trial
Authors: Daryoush Didehdar
Fahimeh Kamali
Amin Kordi Yoosefinejad
Mehrzad Lotfi
Publication date: 01-05-2020
Publisher: Springer London
Keywords: Back Pain
Back Pain
Back Pain
Published in: Irish Journal of Medical Science (1971 -) / Issue 2/2020
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI: https://doi.org/10.1007/s11845-019-02140-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Aim

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2020

Association between vitamin D status in early pregnancy and atopy in offspring in a vitamin D deplete cohort

miR-146a and miR-146b predict increased restenosis and rapid angiographic stenotic progression risk in coronary heart disease patients who underwent percutaneous coronary intervention

“A breath of fresh air” for tackling chronic disease in Ireland? An evaluation of a self-management support service for people with chronic respiratory diseases

Should ultrasound be used routinely in the diagnosis of rheumatoid arthritis?

Risk factors and long-term consequences of new-onset diabetes after renal transplantation

The role of speckle tracking echocardiography in monitoring cardiac function in patients with hereditary hemochromatosis

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials